Comparison Overview
MANKIND PHARMA LTD

MANKIND PHARMA LTD
Phase 3, New Delhi, IN
Last Update: 04/04/2026
Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating...

MSD
90 E Scott Ave, Rahway, New Jersey, US, 07065
Last Update: 01/04/2026
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through...
Compliance Ranges Comparison

MANKIND PHARMA LTD







MSD






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for MANKIND PHARMA LTD in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for MSD in 2026.
Incident History - MANKIND PHARMA LTD (X = Date, Y = Severity)
MANKIND PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.
Incident History - MSD (X = Date, Y = Severity)
MSD cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

MANKIND PHARMA LTD

MSD
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.